[1]
TÖZÜN, N. et al. 2012. Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients. Turkish Journal of Gastroenterology. 23, 5 (Jan. 2012), 552–559. DOI:https://doi.org/10.4318/tjg.2012.0410.